Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...

DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.

DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San ...

In a regulatory filing, DexCom (DXCM) disclosed that on March 4, the company received a warning letter from the U.S. FDA following inspections ...

DexCom (NasdaqGS:DXCM) recently received a warning letter from the FDA, which pointed out issues in manufacturing processes and quality management. While these regulatory developments did not impact ...

DexCom (DXCM) does not expect a material impact from the FDA’s warning letter to its manufacturing capacity or its fiscal year 2025 guidance ...

The U.S. Department of Agriculture has dissolved two key food safety advisory committees, sparking concern over government ...

Dexcom (NASDAQ: DXCM) received a warning letter from the U.S. Food and Drug Administration (FDA) after inspections at its key ...

Dexcom (Nadsaq:DXCM) announced today that it received a warning letter from the FDA following inspections of two company ...

The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...